πŸ‡ΊπŸ‡Έ FDA
Patent

US 9550988

Antisense compounds

granted A61KA61K31/712A61K31/7125

Quick answer

US patent 9550988 (Antisense compounds) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/712, A61K31/7125, A61P, A61P43/00